# FinRobot comparable-company analysis on GEV

_P3_comps — FinRobot pipeline `comps`, generated 2026-09-30 00:09:40_


## Target Data

# GE Vernova Inc. (GEV): Target Data Summary

**Scope:** This summary covers only the two data blocks in the prompt: canonical financials and canonical price. I made no extra tool calls, because the step said to use the supplied data. Items marked "derived" are simple arithmetic on the supplied figures and are not provider values.

---

## 1. Data Source & Timestamps

| Item | Financials block | Price block |
|---|---|---|
| Provider | yfinance (per provenance) | Not stated |
| As of | 2026-09-30T04:04:38Z | 2026-09-29T20:00:02Z |
| Fetched at | 2026-09-30T04:04:38Z | Not stated |
| From cache | **true** | Not stated |
| Degraded flags | **`period_basis_unknown`** | None |
| Warnings | None | None |

---

## 2. Company Profile

| Field | Value |
|---|---|
| Ticker | GEV |
| Company | GE Vernova Inc. |
| Sector / Industry | Industrials / Specialty Industrial Machinery |
| Country | United States |
| Reporting currency | USD |
| Quote currency | USD |
| ADR | null (not provided) |

---

## 3. Income Statement (USD; labeled `ttm`, but provenance says **period basis unknown**, see Section 8)

| Metric | Value | Basis |
|---|---|---|
| Revenue | USD 41.37B | TTM (label unverified) |
| EBITDA | USD 3.93B | TTM (label unverified) |
| Net income | USD 9.53B | TTM (label unverified) |
| Operating income | null | — |
| Gross margin | 20.57% | TTM (label unverified) |
| Operating margin | 7.47% | TTM (label unverified) |
| EBITDA margin (derived: EBITDA ÷ Revenue) | ~9.49% | Derived |
| Net margin (derived: Net income ÷ Revenue) | ~23.04% | Derived |
| Implied operating income (derived: Revenue × operating margin) | ~USD 3.09B | Derived |
| Income tax expense, D&A, R&D, SG&A, interest expense | null | Not provided |

---

## 4. Balance Sheet & Cash Flow (USD)

| Metric | Value | Basis |
|---|---|---|
| Total cash | USD 12.72B | Point in time (period end not given) |
| Total debt | USD 3.72B | Point in time (period end not given) |
| Net cash (derived: cash − debt) | USD 9.00B | Derived |
| Book value per share | USD 44.90 | Point in time |
| Implied book equity (derived: BVPS × shares) | ~USD 11.96B | Derived |
| Preferred stock / Noncontrolling interest | null | Not provided |
| Operating cash flow | USD 14.14B | TTM (label unverified) |
| Capital expenditure | USD −1.58B | TTM (label unverified) |
| FCF (derived: OCF + capex) | ~USD 12.56B | Derived |

---

## 5. Per-Share, Return & Dividend Metrics

| Metric | Value | Notes |
|---|---|---|
| Shares outstanding | 266.33M | — |
| Trailing EPS | USD 35.32 | TTM (label unverified) |
| Forward EPS | USD 25.13 | Forward period not specified |
| Return on equity | 82.58% | Provider value (0.82577) |
| Dividend per share | USD 2.00 | Period not specified (annual assumed, not confirmed) |
| Dividend yield | 0.21 (as provided) | **Unit ambiguous**, see Section 8 |
| Payout ratio | 5.73% | Provider value (0.0573) |

---

## 6. Price Data (USD)

| Metric | Value |
|---|---|
| Current price (close 2026-09-29) | USD 962.49 |
| Latest session change | +USD 12.72 (+1.34%) |
| 52-week high | USD 1,195.94 |
| 52-week low | USD 529.18 |
| Distance from 52-week high (derived) | ~−19.5% |
| Distance above 52-week low (derived) | ~+81.9% |
| Trailing 1-year return | +56.88% |
| Beta | null (not provided) |

**Last five sessions (USD, volume in shares):**

| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2026-09-23 | 950.00 | 954.77 | 934.47 | 951.82 | 1.68M |
| 2026-09-24 | 933.10 | 959.75 | 921.53 | 955.04 | 1.68M |
| 2026-09-25 | 961.33 | 965.34 | 943.39 | 957.63 | 1.38M |
| 2026-09-28 | 953.22 | 967.00 | 944.85 | 949.77 | 1.66M |
| 2026-09-29 | 962.67 | 973.41 | 954.45 | 962.49 | 1.47M |

---

## 7. Valuation Metrics

| Metric | Value | Source |
|---|---|---|
| Market cap | USD 256.34B | Provider |
| P/E (trailing) | 27.25x | Provider |
| Forward P/E | 38.31x | Provider |
| Enterprise value (derived: market cap − net cash; preferred and NCI are null, so left out) | ~USD 247.34B | Derived |
| EV / EBITDA (derived) | ~63.0x | Derived; depends on unverified EBITDA period |
| EV / Revenue (derived) | ~5.98x | Derived |
| Price / Book (derived: 962.49 ÷ 44.895) | ~21.4x | Derived |

**Consistency checks (these pass):**
- Price × shares = ~USD 256.34B, which matches the reported market cap.
- P/E 27.25 × trailing EPS 35.32 = ~USD 962.5, which matches the current price.
- Forward P/E 38.31 × forward EPS 25.13 = ~USD 962.5, which also matches.
- Net income ÷ shares = ~USD 35.78, close to trailing EPS of USD 35.32 (small gap, possibly from share count timing).
- DPS ÷ trailing EPS = ~5.66%, close to the 5.73% payout ratio.

---

## 8. Data Quality Warnings

1. **Period basis conflict:** The `period_basis` field says `"ttm"`, but provenance lists `degraded: ["period_basis_unknown"]`. `period_end` is null and `ttm_quarter_ends` is empty. All flow figures (revenue, EBITDA, net income, OCF, capex, EPS) should be treated as **period unverified**.
2. **Suspicious: net income is higher than EBITDA.** Net income (USD 9.53B) is about 2.4x EBITDA (USD 3.93B). The implied net margin (~23%) is also far above the operating margin (7.47%). Net income normally sits below EBITDA, so this points to large non-operating or one-time items, or to mismatched periods. The data needed to reconcile it (tax, interest, D&A, other income) is null.
3. **Suspicious: trailing EPS is well above forward EPS.** Trailing EPS is USD 35.32 and forward EPS is USD 25.13. This fits with item 2 (trailing earnings may include non-recurring items). The forward period is not specified.
4. **Suspicious: operating cash flow is large compared with EBITDA.** OCF (USD 14.14B) is about 3.6x EBITDA (USD 3.93B). No working-capital breakdown is provided to confirm it.
5. **Dividend yield unit is ambiguous:** The yield is given as `0.21`, while other ratios are decimals (for example, payout ratio 0.0573). USD 2.00 ÷ USD 962.49 = ~0.21%, so the field appears to be **already in percent (0.21%)** and not 21%. Treat it as a unit inconsistency.
6. **High ROE (82.58%)** is probably inflated by the net income in item 2. A derived check (net income ÷ implied equity) gives ~79.7%.
7. **Cached data:** The financials block has `from_cache: true`.
8. **Timestamps differ:** Financials are as of 2026-09-30 04:04 UTC and price is as of 2026-09-29 20:00 UTC, about 8 hours apart.
9. **`current_price` is null in the financials block.** The price above comes from the price block.


## Output Gen

# GE Vernova Inc. (GEV): Equity Research Report

**Sector / Industry:** Industrials / Specialty Industrial Machinery | **Country:** United States | **Reporting / Quote Currency:** USD
**Price as of:** 2026-09-29 close (USD 962.49) | **Financials as of:** 2026-09-30T04:04:38Z (cached)

---

## 1. Executive Summary

| Item | Status |
|---|---|
| **Recommendation** | **Not available.** No investment-thesis step output was supplied. |
| **Price target** | **Not available.** No valuation-synthesis or thesis output was supplied, so no point target can be stated. |
| **Peer-relative positioning** | **Not available.** No `peer_analysis` output was supplied. |
| **Data health** | **Degraded.** Period basis is unverified (`period_basis_unknown`), and there are several internal inconsistencies in the TTM figures (see Section 8). |

The previous steps produced only target-company data (a TTM snapshot, market data and FY2022–FY2025 history). This report does not create a recommendation or price target, because none exists in the structured data.

### Key Metrics Snapshot

| Metric | Value | Basis |
|---|---|---|
| Share price | USD 962.49 | Close 2026-09-29 |
| Market cap | USD 256.34B | Current |
| Enterprise value | USD 247.34B | Current¹ |
| Revenue | USD 41.37B | TTM² |
| EBITDA | USD 3.93B | TTM² |
| Net income | USD 9.53B | TTM²,³ |
| P/E (trailing) | 27.25x | TTM² |
| P/E (forward) | 38.31x | Forward, period not specified |
| EV / EBITDA | ~63.0x | TTM² |
| EV / Revenue | ~5.98x | TTM² |
| Net cash | USD 9.00B | Point in time, period end not given |
| Trailing 1-year return | +56.88% | 1Y to 2026-09-29 |

¹ EV = market cap − net cash. Preferred stock and noncontrolling interest are null and are left out of the calculation.
² The data is labeled "TTM", but provenance flags `period_basis_unknown`. `fiscal_period_end` is null and `ttm_quarter_ends` is empty. Treat the period as **unverified**.
³ TTM net income is about 2.4x TTM EBITDA. This is an unreconciled anomaly (see Section 8).

---

## 2. Company Overview

| Field | Value |
|---|---|
| Company | GE Vernova Inc. |
| Ticker | GEV |
| Sector | Industrials |
| Industry | Specialty Industrial Machinery |
| Country | United States |
| Shares outstanding | 266.33M |
| ADR status | Not provided |
| Beta | Not provided |

No business-segment, product or management information was provided in previous steps.

---

## 3. Financial Summary

### 3.1 TTM Snapshot (USD; period basis unverified²)

| Metric | Value | Margin |
|---|---|---|
| Revenue | USD 41.37B | — |
| Gross profit | n/a | 20.57% gross margin (provider) |
| Operating income | Not provided (null) | 7.47% operating margin (provider) |
| Implied operating income | ~USD 3.09B | Approximation: revenue × operating margin⁴ |
| EBITDA | USD 3.93B | ~9.49% (derived) |
| Net income | USD 9.53B³ | ~23.04% (derived)³ |
| Trailing EPS | USD 35.32 | — |
| Forward EPS | USD 25.13 | Forward period not specified |

⁴ This is an approximate figure. Reported operating income is null, so it is derived from the provider's margin.

Tax expense, D&A, interest expense, R&D and SG&A are not provided for the TTM period.

### 3.2 Historical Annual Performance (FY2022–FY2025)⁵

| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | 29.65B | 33.24B | 34.94B | 38.07B |
| Revenue growth YoY | — | 12.09% | 5.10% | 8.97% |
| Gross profit | 3.46B | 4.82B | 6.09B | 7.54B |
| Gross margin | 11.66% | 14.50% | 17.42% | 19.79% |
| SG&A | 5.36B | 4.85B | 4.63B | 4.95B |
| SG&A / revenue | 18.08% | 14.58% | 13.26% | 13.00% |
| EBITDA | −0.53B | 0.93B | 1.64B | 2.24B |
| EBITDA margin | −1.77% | 2.80% | 4.70% | 5.89% |
| Operating income | −2.88B | −0.92B | 0.47B | 1.39B |
| Operating margin | −9.72% | −2.78% | 1.35% | 3.65% |
| Net income | −2.74B | −0.44B | 1.55B | 4.88B |
| EPS | −10.06 | −1.60 | 5.65 | 17.96 |
| D&A | 1.80B | 0.96B | 1.17B | 0.85B |

**Revenue CAGR (FY2022–FY2025):** 8.68%

⁵ The historical block reports `currency: null`. USD is inferred from the target data's reporting currency. The fiscal year-end date is not specified. The FY2025 `pe_ratio` field (27.25x) is identical to the current trailing P/E. It appears to reflect the current price against TTM EPS, not FY2025 EPS (USD 17.96), so it should not be read as a FY2025 multiple.

### 3.3 Cash Flow

| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | TTM² |
|---|---|---|---|---|---|
| Operating cash flow | −0.11B | 1.19B | 2.58B | 4.99B | 14.14B⁶ |
| Capital expenditure⁷ | 0.51B | 0.74B | 0.88B | 1.28B | 1.58B |
| Investing cash flow | −0.32B | −0.73B | −0.04B | −0.76B | n/a |
| Financing cash flow | 0.81B | −0.41B | 3.65B | −3.81B | n/a |
| Change in working capital | 0.58B | 1.13B | 1.12B | 4.10B | n/a |
| FCF (OCF − capex) | n/a | n/a | n/a | n/a | ~12.56B (derived)⁶ |

⁶ TTM OCF is about 3.6x TTM EBITDA and about 2.8x FY2025 OCF. No working-capital breakdown is available to reconcile this.
⁷ Sign conventions differ between sources. Historical capex is reported as a positive number, and TTM capex is reported as negative (USD −1.58B). Both are shown here as absolute outflows.

### 3.4 Balance Sheet (point in time; period end not given)

| Metric | Value |
|---|---|
| Total cash | USD 12.72B |
| Total debt | USD 3.72B |
| Net cash | USD 9.00B (derived) |
| Book value per share | USD 44.90 |
| Implied book equity | ~USD 11.96B (derived) |
| Preferred stock / NCI | Not provided |
| Shareholders' equity (historical) | Not provided (null for all years) |

### 3.5 Returns & Shareholder Distributions

| Metric | Value | Note |
|---|---|---|
| Return on equity | 82.58% | Likely inflated by the TTM net income anomaly³ |
| Dividend per share | USD 2.00 | Period not specified; annual basis assumed but not confirmed |
| Dividend yield | ~0.21% | Provider field reads `0.21`. The unit is ambiguous; USD 2.00 ÷ USD 962.49 ≈ 0.21% |
| Payout ratio | 5.73% | Provider value |

---

## 4. Peer Analysis

**No peer analysis output was supplied in previous steps.** There is no peer set, no peer multiples and no peer medians. For this reason, this report makes **no** statement about GEV trading at a premium or discount to peers.

---

## 5. Valuation

### 5.1 Subject-Company Trading Multiples

| Multiple | Value | Basis | Source |
|---|---|---|---|
| P/E (trailing) | 27.25x | TTM² | Provider |
| P/E (forward) | 38.31x | Forward, period not specified | Provider |
| EV / EBITDA | ~63.0x | TTM² | Derived |
| EV / Revenue | ~5.98x | TTM² | Derived |
| Price / Book | ~21.4x | Current | Derived |

### 5.2 Valuation Caveats

- **No valuation methods were run.** No DCF, comps-implied or synthesis output was supplied. There is no method cross-check, no outlier assessment and no confidence-weighted target.
- **The P/E multiples are hard to interpret.** Forward P/E (38.31x) is above trailing P/E (27.25x) because forward EPS (USD 


## Warnings raised by FinRobot

- Step statistical_bench degraded (validation failed): executor error (non-recoverable, degrading and continuing): ValueError: peer candidates unavailable for GEV: Data unavailable (GEV / peer_candidates): all data sources failed and no cache is available.